Opinion|Videos|January 9, 2024
Identifying the Right CDMO to Support Biopharma Manufacturing
Author(s)Ascendia Pharma
Robert Bloder, Chief Business Officer, Ascendia Pharmaceuticals discusses:
- What to look for when identifying a CDMO for a drug development project
- Ascendia Pharmaceuticals and its expansion of manufacturing services
- Ascendia Pharmaceuticals as a "Partner of Choice"
Related Content
Trending on Pharmaceutical Technology
1
Brent Wilhelm on Why Drug Shortages Persist Despite Available Inventory
2
FDA Activity Round Up – July 2026
3
Can Governance-by-Design Make AI Compliant in Pharma? (Part II)
4
From Predictions to Reality: Mike Stenberg Assesses Pharma Manufacturing's First Half of 2026
5